close
MENU
General Business
1 mins to read

Covid testing lifts profit for pathology provider

APHG, now part owned by the Super Fund, reports profit up 17%.

Tim Hunter Thu, 06 May 2021

Pathology group APHG has posted a bumper profit for the year to December, boosted by its major role in providing Covid-19 tests.

Net profit for the year was $40.4 million from revenue of $307.7m, up from $34.4m and $264.3m respectively in the year to June 2019 before a change of balance

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Tim Hunter Thu, 06 May 2021
Contact the Writer: thunter@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Covid testing lifts profit for pathology provider
General Business,
87265
true